BPA Call W81K0020A0014-W81K0023F0142
Award Date
10/1/23
Potential Completion Date
9/30/24
Potential Value
$80K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Medical Command
Awardee
Pharmalucence, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
2330 Stanley Rd, Fort Sam Houston, TX 78234, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price blanket purchase agreement (BPA) call contract awarded by the Defense Health Agency (DHA) to Pharmalucence, Inc. for the supply of radiopharmaceuticals and related products. The contract has a ceiling value of $75,000.00 and a period of performance through September 30, 2024. Pharmalucence, Inc. is a specialty pharmaceutical company focused on manufacturing and distributing generic radiopharmaceutical products and supplies. The DHA, a component of the Department of...
This is a firm fixed-price blanket purchase agreement (BPA) call contract awarded by the Defense Health Agency (DHA), a component of the Department of Defense, to Pharmalucence, Inc. for the supply of various radiopharmaceuticals. The $100,000.00 contract has an ultimate completion date of September 30, 2025 and does not have a set-aside designation. Pharmalucence, Inc. is a specialty pharmaceutical company focused on manufacturing and distributing generic radiopharmaceutical products and...
This contract was awarded by the Defense Health Agency (DHA) to Pharmalucence, Inc., a specialty pharmaceutical manufacturer, to provide radiopharmaceuticals and supplies. The contract is a firm fixed price blanket purchase agreement (BPA) call with a potential value of $25,000.00 and a completion date of September 30, 2023. The products will be delivered to facilities in El Paso, Texas to support nuclear medicine diagnostic services for the Military Health System's 9.5 million beneficiaries....
This is a federal contract award to Medi-Physics, Inc., a subsidiary of General Electric Company operating as GE Healthcare, for the provision of radiopharmaceuticals and supplies to the Defense Health Agency (DHA). The contract, with a ceiling value of $150,000.00, is a Blanket Purchase Agreement (BPA) call with a firm fixed price pricing type. The award has an ultimate completion date of September 30, 2025. Medi-Physics, a large, for-profit manufacturing company, is a prominent supplier of...
This is a $375,785.71 fixed-price with economic price adjustment purchase order contract awarded to Lantheus Medical Imaging, Inc. by the Defense Health Agency (DHA) for the procurement of radiopharmaceutical diagnostic products. The contract is set aside for small businesses and has an ultimate completion date of December 31, 2014. Lantheus Medical Imaging, a for-profit manufacturer of diagnostic medical imaging agents and products, is the prime contractor. The contract is part of a larger...
This federal contract award to Curium US LLC, a foreign-owned for-profit manufacturer of radiopharmaceuticals and nuclear medicine products, is a Blanket Purchase Agreement (BPA) call with a value of $249,999.96. The contract is with the Defense Health Agency (DHA) to provide radiopharmaceuticals, supplies, and related services to support healthcare operations at military medical facilities. The BPA allows DHA to issue firm fixed price call orders for Curium to deliver products such as...
This is a federal contract award by the Defense Health Agency (DHA) to Medi-Physics, Inc., doing business as GE Healthcare, a subsidiary of General Electric Company. The contract, valued at a ceiling of $100,000.00, is a Blanket Purchase Agreement (BPA) call for the delivery of various radiopharmaceuticals. The contract has a period of performance through September 30, 2025 and uses a Firm Fixed Price pricing structure. This contract does not have a small business set-aside designation, as...
This federal contract award is for the provision of radiopharmaceuticals and supplies by Curium US LLC, a foreign-owned, for-profit manufacturer, to the Defense Health Agency (DHA) and the U.S. Army Medical Command. The contract, with a ceiling value of $200,000.00, is a Blanket Purchase Agreement (BPA) call with a firm fixed price pricing type, awarded on October 1, 2023. The contract supports the agency's healthcare operations for over 9.4 million beneficiaries, with deliveries of...
The Defense Health Agency awarded a $60,300 firm fixed price blanket purchase agreement call contract to Petnet Solutions, Inc. for the delivery of radiopharmaceuticals. As the parent company, Siemens Aktiengesellschaft will likely support Petnet Solutions in fulfilling the contract requirements. Performance will take place at Joint Base San Antonio-Fort Sam Houston in Texas by September 30, 2023. No set-aside provisions were specified. The radiopharmaceuticals will support healthcare programs...
This is a firm-fixed price delivery order contract awarded by the Department of Veterans Affairs (VA) to Pharmalogic Holdings Corp., doing business as Pharmalogic Puerto Rico, a for-profit organization. The contract, with a ceiling value of $978,250.00, is for the supply of F18-florbetapir (NeuraCeq) radiopharmaceutical in single-unit doses to support nuclear medicine diagnostic imaging procedures at VA medical facilities. The contract is structured as a Blanket Purchase Agreement (BPA) call and...